Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark

References

• Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–125.
   PubMed Web of Science ®Google Scholar
• Chang M-H. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007;12:160–167.
   PubMed Web of Science ®Google Scholar
• Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49:S35–S44.
   PubMed Web of Science ®Google Scholar
• Chien Y-C, Jan C-F, Kuo H-S, et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev. 2006;28:126–135.
   PubMed Web of Science ®Google Scholar
• del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine Oktober. 1997;15:1624–1630.
   PubMed Web of Science ®Google Scholar
• Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18:468–473.
   PubMed Web of Science ®Google Scholar
• Song Y-M, Sung J, Yang S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007;166:813–818.
   PubMed Web of Science ®Google Scholar
• Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190:489–492.
   PubMed Web of Science ®Google Scholar
• Xu D-Z, Yan Y-P, Choi BCK, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67:20–26.
   PubMed Web of Science ®Google Scholar
• Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–1457.
   PubMed Web of Science ®Google Scholar
• Shi Z, Yang Y, Ma L, et al. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:147–159.
   PubMed Web of Science ®Google Scholar
• Xu W-M, Cui Y-T, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94–103.
   PubMed Web of Science ®Google Scholar
• Christensen PB, Clausen MR, Krarup H, et al. Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection – Danish national guidelines 2011. Dan Med J. 2012;59:C4465.
   Web of Science ®Google Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287:2398–2399.
   PubMed Web of Science ®Google Scholar
• Hansen N, Obel N, Christensen PB, et al. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. J Viral Hepat. 2009;16:659–665.
   PubMed Web of Science ®Google Scholar
• Krarup HB, Andersen S, Madsen PH, et al. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol. 2008;43:334–343.
   PubMed Web of Science ®Google Scholar
• Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39:362–364.
   PubMed Web of Science ®Google Scholar
• Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–413.
   Web of Science ®Google Scholar
• Heagerty P, Zeger SL. Marginal regression models for clustered ordinal measurements. J Am Stat Assoc. 1996;91:1024–1036.
   Web of Science ®Google Scholar
• A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. R Lang. Environ. Stat. Comput. [Internet]. [cited 2016 Jan 21]. Available from: https://www.r-project.org/.
   Google Scholar
• WHO Hepatitis B Fact Sheet. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
   Google Scholar
• Hansen N, Hay G, Cowan S, et al. Hepatitis B prevalence in Denmark – an estimate based on nationwide registers and a national screening programme, as on 31 December 2007. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2013;18:
   Google Scholar
• Cowan SA. Denmark scales up hepatitis B screening and vaccination for risk groups. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2005;10:E051103.4.
   Google Scholar
• Harder KM, Cowan S, Eriksen MB, et al. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark. Vaccine. 2011;29:9303–9307.
   PubMed Web of Science ®Google Scholar
• https://sundhedsstyrelsen.dk/∼/media/AD9E0753B12546B8AEA323BF02AC3D2C.ashx
   Google Scholar
• Lu C-Y, Chiang B-L, Chi W-K, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatol Baltim Md. 2004;40:1415–1420.
   PubMed Web of Science ®Google Scholar
• Boxall EH, A, Sira J, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190:1264–1269.
   PubMed Web of Science ®Google Scholar
• Mele A, Tancredi F, Romanò L, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis. 2001;184:905–908.
   PubMed Web of Science ®Google Scholar
• Young BWY, Lee SS, Lim WL, et al. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat. 2003;10:23–30.
   PubMed Web of Science ®Google Scholar
• Lu C-Y, Ni Y-H, Chiang B-L, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008;197:1419–1426.
   PubMed Web of Science ®Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2006;55:1–33.
   PubMedGoogle Scholar
• Shahmoradi S, Yahyapour Y, Mahmoodi M, et al. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol. 2012;57:515–521.
   PubMed Web of Science ®Google Scholar
• Krarup H, Andersen S, Madsen PH, et al. HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: a nationwide cohort study. Scand J Gastroenterol. 2011;46:1484–1491.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang C, Jia Z-F, et al. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with the immunoprophylaxis failure. Medicine. 2016;95:1–8.
   Web of Science ®Google Scholar